Read More

WuXi Biologics Announces Research Service Agreement With BioNTech On Discovering Investigational Monoclonal Antibodies For Developing Next-Generation Therapeutic Product Candidates; WuXi Biologics Will Receive A $20M Upfront Payment

WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its Research Service Unit (R in CRDMO) has signed a research service

BNTX

Read More

Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy

Lars Fruergaard Jorgensen, CEO of Novo Nordisk A/S (NYSE: NVO), shared insights during the JPMorgan Healthcare conference, highlighting Wegovy's efficacy for weight loss, indicating that patients are likely to continue with Wegovy for more extended periods compared to 

LLY

Read More

Stocks Flip To Losses, Nvidia Defies Gravity, Bitcoin Pauses For A Breather: What’s Driving Markets Tuesday?

Tuesday on Wall Street was marked by a subdued trend in major equity indices as investors remained cautious ahead of key inflation data scheduled for release on Thursday and the kick-off of the earnings season.

AMD